Neurology Diagnostic and Monitoring Devices Market to Reach USD 24.9 Billion by 2036, Expanding at 7.2% CAGR

The global neurology diagnostic and monitoring devices market reached USD 12.4 billion in 2025 and is expected to reach USD 24.9 billion by 2036, expanding at a CAGR of 7.2% from 2026 to 2036. Market growth is driven by the increasing prevalence of neurological disorders, rising demand for advanced diagnostic and monitoring technologies, growing healthcare expenditure, and continuous advancements in medical imaging and neurological monitoring devices.

As early intervention becomes critical for treating conditions like Alzheimer's, Parkinson's, epilepsy, and stroke, neurology systems are evolving from static diagnostic machinery into real-time, AI-assisted monitoring tools integrated directly into clinical and remote environments.

Review significant findings and insights from our Report in this sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85936

Market Overview

Neurology diagnostic and monitoring devices encompass equipment designed to evaluate, map, and measure the structural and functional status of the human central and peripheral nervous systems.

The industry's scope covers Diagnostic Imaging Systems (MRI, CT scanners, PET systems), Neurofunctional Systems (EEG, MEG, EMG), and Intraoperative / Critical Care Monitors (ICP monitors, cerebral oximeters). Rapid adoption of ultra-high-field MRI, wearable EEG telemetry, and miniaturized intracranial pressure sensors is shifting neuro-care toward decentralized, continuous patient monitoring.

Key Market Growth Drivers

• Surging Prevalence of Neurological Disorders: Rising global incidence of stroke, epilepsy, dementia, traumatic brain injuries (TBI), and movement disorders is escalating the demand for baseline diagnostic workups and continuous patient monitoring.
• Integration of Artificial Intelligence and Machine Learning: AI-driven software integrated with imaging and EEG platforms allows for automated spike detection, early biomarker recognition, and predictive stroke analytics, reducing diagnostic turnaround times.
• Transition Toward Non-Invasive Continuous Monitoring: Healthcare facilities are favoring non-invasive cerebral oximetry, transcranial Doppler (TCD), and wearable ambulatory EEGs over invasive alternatives to enhance patient comfort and prevent hospital-acquired complications.
• Expanding Healthcare Infrastructure and Outpatient Neuro-Centers: Rising investments in specialized ambulatory care centers, dedicated stroke units, and diagnostic imaging laboratories are scaling global equipment procurement beyond traditional acute-care hospitals.

Analysis of Key Players

The competitive landscape of the neurology diagnostic and monitoring devices market is consolidated, featuring major medical technology and imaging conglomerates:

• GE HealthCare Technologies Inc.
• Neurosoft
• Canon Medical Systems Corporation
• FUJIFILM Holdings Corporation
• Koninklijke Philips N.V.
• Siemens Healthineers AG
• Shimadzu Corporation
• United Imaging Healthcare Co., Ltd.
• Esaote S.p.A.
• Nihon Kohden Corporation
• Natus Medical Incorporated
• Cadwell Industries, Inc.
• Ceribell, Inc.
• Masimo Corporation
• Compumedics Limited
• Elekta AB
• Medtronic plc
• Advanced Brain Monitoring, Inc.
• Blackrock Neurotech
• NeuroMetrix, Inc.
• Other Key Players

Key Developments in the Neurology Diagnostic and Monitoring Devices Market

• In May 2026, Philips announced Titanion MR, an ultra-high-gradient 3.0T MRI system, at ISMRM 2026. The company stated that the system is designed to advance MRI beyond anatomical and functional imaging toward whole-body quantitative biomarkers.
• In April 2026, Canon Inc. announced the launch of Ultimion, Japan’s first domestically produced photon-counting CT system. The launch strengthens Canon Medical Systems’ advanced diagnostic imaging portfolio.
• In February 2026, GE HealthCare received FDA 510(k) clearances for next-generation SIGNA MRI technologies, including SIGNA Sprint with Freelium, SIGNA Bolt, and SIGNA One. The company stated that these technologies are designed to enhance precision imaging, sustainability, productivity, and clinical efficiency.
• In January 2026, Siemens Healthineers received U.S. FDA clearance for Biograph One, its second-generation PET/MR imaging scanner. The system enables simultaneous visualization of organ location, function, and cellular metabolism.

Access detailed insights by visiting our full report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=85936

Market Challenges & Opportunities

Challenges

• High Capital Costs & Maintenance Outlays: Advanced neuroimaging machinery (such as 3T/7T MRI scanners and PET-CT units) requires significant initial capital expenditure, limiting rapid adoption in low-resource facilities.
• Shortage of Skilled Technicians & Neuro-Physiologists: Interpreting complex continuous EEG and functional neuro-imaging datasets requires specialized expertise, creating operational bottlenecks in high-volume hospitals.

Opportunities

• Ambulatory and Remote Neuro-Monitoring: Deploying cloud-connected wearable EEGs and home-monitoring platforms for long-term epilepsy management and remote clinical trials.
• Early Dementia & Alzheimer's Biomarker Diagnostics: Growing availability of targeted disease-modifying therapies is driving demand for early-stage PET imaging and high-sensitivity diagnostic equipment.

Market Segmentation

Frequently Asked Questions

·        What is the market size of the Neurology Diagnostic and Monitoring Devices Market?

The global Neurology Diagnostic and Monitoring Devices Industry was valued at USD 12.4 Billion in 2025.

·        What is the forecast value of the Neurology Diagnostic and Monitoring Devices Industry by 2036?

The global Neurology Diagnostic and Monitoring Devices Industry is projected to reach USD 24.9 Billion by 2036.

·        What is the CAGR of the Neurology Diagnostic and Monitoring Devices Market?

The Neurology Diagnostic and Monitoring Devices Market is expected to expand at a CAGR of 7.2% from 2026 to 2036.

·        Which device type leads the Neurology Diagnostic and Monitoring Devices Market?

Electroencephalography (EEG) Devices lead the market with a 28.0% share in 2025.

·        Which region dominates the Neurology Diagnostic and Monitoring Devices Market?

North America dominates the Neurology Diagnostic and Monitoring Devices Market with a 40.0% revenue share in 2025.

Buy this Premium Research Report to gain valuable industry intelligence - https://www.transparencymarketresearch.com/checkout.php?rep_id=85936<ype=S

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Abhishek Budholiya

Transparency Market Research Inc.

State Tower, 90 State Street, Suite 700,

Albany NY - 12207, United States

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com  

Sales Inquiries: sales@transparencymarketresearch.com  

Media Inquiries: media@transparencymarketresearch.com